✦ LIBER ✦

Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia

✍ Scribed by E. Peselow; B. Angrist; A. Sudilovsky; J. Corwin; J. Siekierski; F. Trent; J. Rotrosen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholecystokinin-octapeptide in chronic s

✍ Nair, N.P.V.; Bloom, D.M.; Debonnel, G.; Schwartz, G.; Mosticyan, S. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Double-blind, placebo-controlled, cross-

✍ P. Diaz; S. Bhaskara; S.M. Dursun 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Double-Blind Placebo-Controlled Trial of

✍ Morgan, Matt; Cooke, Andrew; Rogers, Laura; Adams-Huet, Beverley; Khan, David A. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 500 KB

Blonanserin for schizophrenia: Systemati

✍ Taro Kishi; Yuki Matsuda; Hiroshi Nakamura; Nakao Iwata 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A negative, double-blind, placebo-contro

✍ Jack A. Grebb; Richard C. Shelton; Edward H. Taylor; Llewellyn B. Bigelow 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Comparing the efficacy of atypical antip

✍ Frank-Gerald Pajonk; Rüdiger Holzbach; Dieter Naber 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 49 KB